Orion, Bayer prostate cancer drug gets FDA approval

Finland's Orion and Germany's Bayer said on Wednesday the U.S. Food and Drug Administration (FDA) had approved prostate cancer drug daroluramide, which the two companies have been developing together.


from Reuters: Health News https://ift.tt/2Mu4xKP

Comentarii

Postări populare de pe acest blog

Telehealth hubs offer care options for people living on the edge the virtual world

The daily coronavirus update: Double-digit deaths for second day in a row; 82,716 total cases

Overuse on cattle feedlots is a key factor in antibiotic resistance, report says